Compare FLYW & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLYW | PRGO |
|---|---|---|
| Founded | 2009 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2021 | 2013 |
| Metric | FLYW | PRGO |
|---|---|---|
| Price | $21.12 | $16.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $23.39 | $18.00 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 7.23% |
| EPS Growth | ★ 450.00 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $623,025,000.00 | $800,000.00 |
| Revenue This Year | $24.36 | N/A |
| Revenue Next Year | $14.91 | N/A |
| P/E Ratio | $35.07 | ★ N/A |
| Revenue Growth | ★ 26.59 | N/A |
| 52 Week Low | $10.55 | $9.23 |
| 52 Week High | $22.59 | $17.07 |
| Indicator | FLYW | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 53.37 | 50.50 |
| Support Level | $16.95 | $9.93 |
| Resistance Level | $22.59 | $16.91 |
| Average True Range (ATR) | 0.99 | 0.81 |
| MACD | -0.11 | -0.07 |
| Stochastic Oscillator | 55.42 | 44.36 |
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix centers on private-label consumer health goods sold to major retailers such as Walmart, Amazon.com, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.